Background: Angiotensin-converting-enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) work

Background: Angiotensin-converting-enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) work treatments for diabetic retinopathy, but randomized studies and meta-analyses comparing their results in macrovascular complications possess yielded conflicting outcomes. were comparable to ACE inhibitors in threat of all-cause loss…